WallStreetZenWallStreetZen

NASDAQ: ADXN
Addex Therapeutics Ltd Earnings & Revenue

ADXN past revenue growth

How has ADXN's revenue growth performed historically?
Company
26.2%
Industry
81.2%
Market
15.74%
ADXN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ADXN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ADXN's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ADXN earnings and revenue history

Current Revenue
$2.0M
Current Earnings
-$12.6M
Current Profit Margin
-640.9%

ADXN Return on Equity

Current Company
-276.2%
Current Industry
-63.5%
Current Market
188%
ADXN's Return on Equity (-276.2%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ADXN announces earnings.

ADXN Return on Assets

Current Company
-156%
Current Industry
2.9%
ADXN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ADXN Return on Capital Employed

Current Company
-584.31%
Current Industry
19.5%
ADXN's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ADXN vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ADXN$1.83M-$11.01M-$11.73M-22.11%N/A
MTEM$31.76M-$11.28M-$18.40M+9.90%N/A
KTRA$0.00-$9.37M-$9.51MN/AN/A
BCDA$468.00k-$9.92M-$10.34M-6.13%N/A
BRTX$145.80k-$14.16M-$14.42M+5.61%N/A

Addex Therapeutics Earnings & Revenue FAQ

What were ADXN's earnings last quarter?

Addex Therapeutics (NASDAQ: ADXN) reported Q4 2023 earnings per share (EPS) of -$0.04, up 16.28% year over year. Total Addex Therapeutics earnings for the quarter were -$3.40 million. In the same quarter last year, Addex Therapeutics's earnings per share (EPS) was -$0.04.

If you're new to stock investing, here's how to buy Addex Therapeutics stock.

What was ADXN's earnings growth in the past year?

As of Q2 2024, Addex Therapeutics's earnings has grown year over year. Addex Therapeutics's earnings in the past year totalled -$11.73 million.

What was ADXN's revenue last quarter?

Addex Therapeutics (NASDAQ: ADXN) reported Q4 2023 revenue of $218.84 thousand up 66.02% year over year. In the same quarter last year, Addex Therapeutics's revenue was $643.95 thousand.

What was ADXN's revenue growth in the past year?

As of Q2 2024, Addex Therapeutics's revenue has grown 26.2% year over year. This is 55 percentage points lower than the US Biotechnology industry revenue growth rate of 81.2%. Addex Therapeutics's revenue in the past year totalled $1.83 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.